{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:06:49Z","timestamp":1789736809200,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.vaccine.2010.09.020","type":"journal-article","created":{"date-parts":[[2010,9,24]],"date-time":"2010-09-24T06:26:17Z","timestamp":1285309577000},"page":"886-889","source":"Crossref","is-referenced-by-count":58,"title":["Guillain\u2013Barr\u00e9 syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006\u20132009"],"prefix":"10.1016","volume":"29","author":[{"given":"Nizar","family":"Souayah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Michas-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu","family":"Nasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"Krivitskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussam A.","family":"Yacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan I.","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.09.020_bib0005","unstructured":"Product approval information-licensing action. GARDASIL\u00ae questions and answers. http:\/\/www.asccp.org\/pdfs\/hpv\/FDAFactSheet.pdf [accessed 01.03.10]."},{"issue":"May (19)","key":"10.1016\/j.vaccine.2010.09.020_bib0010","first-page":"1915","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"issue":"June (9580)","key":"10.1016\/j.vaccine.2010.09.020_bib0015","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"issue":"May (9574)","key":"10.1016\/j.vaccine.2010.09.020_bib0020","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","article-title":"Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials","volume":"369","author":"Joura","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.09.020_bib0025","series-title":"An analysis by the National Vaccine Information Center of Gardasil & Menactra adverse event reports to the Vaccine Adverse Events Reporting System (VAERS)","year":"2009"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2010.09.020_bib0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain\u2013Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2010.09.020_bib0035","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/oxfordjournals.aje.a115973","article-title":"Reassessment of the association between Guillain\u2013Barre syndrome and receipt of swine influenza vaccine in 1976\u20131977: results of a two-state study. Expert Neurology Group","volume":"133","author":"Safranek","year":"1991","journal-title":"Am J Epidemiol"},{"issue":"29","key":"10.1016\/j.vaccine.2010.09.020_bib0040","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1016\/j.vaccine.2007.03.053","article-title":"Guillain\u2013Barre syndrome after vaccination in United States a report from the CDC\/FDA Vaccine Adverse Event Reporting System","volume":"July (25)","author":"Souayah","year":"2007","journal-title":"Vaccine"},{"issue":"December (25)","key":"10.1016\/j.vaccine.2010.09.020_bib0045","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","article-title":"The Guillain\u2013Barre syndrome and the 1992\u20131993 and 1993\u20131994 influenza vaccines","volume":"339","author":"Lasky","year":"1998","journal-title":"N Engl J Med"},{"issue":"September (1)","key":"10.1016\/j.vaccine.2010.09.020_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CND.0b013e3181aaa968","article-title":"Guillain\u2013Barre syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention\/Food and Drug Administration Vaccine Adverse Event Reporting System (1990\u20132005)","volume":"11","author":"Souayah","year":"2009","journal-title":"J Clin Neuromuscul Dis"},{"issue":"November (20)","key":"10.1016\/j.vaccine.2010.09.020_bib0055","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","article-title":"Guillain\u2013Barre syndrome following influenza vaccination","volume":"292","author":"Haber","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2010.09.020_bib0060","unstructured":"Reports of health concerns following HPV vaccination. http:\/\/www.cdc.gov\/vaccinesafety\/Vaccines\/HPV\/gardasil.html [accessed 31.01.10]."},{"key":"10.1016\/j.vaccine.2010.09.020_bib0065","unstructured":"Sanofi Pasteur presents safety data on Menactra(R) vaccine given to infants at infectious disease society meeting. http:\/\/www.prnewswire.com\/news-releases\/sanofi-pasteur-presents-safety-data-on-menactrar-vaccine-given-to-infants-at-infectious-disease-society-meeting-68531367.html [accessed 01.03.10]."},{"key":"10.1016\/j.vaccine.2010.09.020_bib0070","unstructured":"Menactra meningococcal vaccine and Guillain\u2013Barr\u00e9 syndrome. http:\/\/www.who.int\/vaccine_safety\/topics\/meningococcal\/GBS\/en\/index.html [accessed 01.03.10]"},{"key":"10.1016\/j.vaccine.2010.09.020_bib0075","unstructured":"National Health Interview Survey (NHIS). http:\/\/www.cdc.gov\/nchs\/nhis.htm [accessed 02.02.10]."},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.020_bib0080","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain\u2013Barre syndrome worldwide. A systematic literature review","volume":"32","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.020_bib0085","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1067\/mpd.2001.111165","article-title":"Risk of Guillain\u2013Barre syndrome after measles-mumps-rubella vaccination","volume":"138","author":"Patja","year":"2001","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.vaccine.2010.09.020_bib0090","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/jnnp.51.5.613","article-title":"A prospective study of acute idiopathic neuropathy. II. Antecedent events","volume":"51","author":"Winer","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.020_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jaut.1999.0346","article-title":"Vaccination and autoimmunity-\u2019vaccinosis\u2019: a dangerous liaison?","volume":"14","author":"Shoenfeld","year":"2000","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.020_bib0100","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1521-6616(03)00046-9","article-title":"Influenza vaccination and Guillain\u2013Barre syndrome small star, filled","volume":"107","author":"Geier","year":"2003","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.020_bib0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4161\/hv.3.4.4058","article-title":"Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions","volume":"3","author":"Smith","year":"2007","journal-title":"Hum Vaccin"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2010.09.020_bib0110","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jnci\/93.4.284","article-title":"Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine","volume":"93","author":"Harro","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"September (3 Suppl. 2)","key":"10.1016\/j.vaccine.2010.09.020_bib0115","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.ygyno.2008.05.011","article-title":"Cervical cancer vaccination indications, efficacy, and side effects","volume":"110","author":"Bayas","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.020_bib0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00019052-200206000-00018","article-title":"Neurological adverse events associated with vaccination","volume":"15","author":"Piyasirisilp","year":"2002","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.020_bib0125","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s001340050025","article-title":"An uncommon cause of lower limb weakness","volume":"26","author":"Berlot","year":"2000","journal-title":"Intensive Care Med"},{"issue":"August (9125)","key":"10.1016\/j.vaccine.2010.09.020_bib0130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(98)02326-5","article-title":"Macrophagic myofasciitis: an emerging entity. Groupe d\u2019Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l\u2019Association Francaise contre les Myopathies (AFM)","volume":"352","author":"Gherardi","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2010.09.020_bib0135","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/brain\/124.5.974","article-title":"Central nervous system disease in patients with macrophagic myofasciitis","volume":"124","author":"Authier","year":"2001","journal-title":"Brain"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10013307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10013307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T22:06:07Z","timestamp":1559685967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10013307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0264410X10013307"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.09.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}